Product Comparison


  Chiesi USA Inc 10122051003 ONY 61938045606

No Image

Chiesi USA Inc 10122051001

No Image

McKesson # 804717 903936 841702 805145 463604
Description Curosurf® Poractant Alfa, Preservative Free 80 mg / mL Suspension 3 mL Infasurf® Calfactant 35 mg / mL Suspension 6 mL Survanta® Beractant 25 mg / mL Suspension 4 mL Curosurf® Poractant Alfa, Preservative Free 80 mg / mL Suspension 1.5 mL Survanta® Beractant 25 mg / mL Suspension 8 mL
Manufacturer # 1012205100361938045606000741040041012205100100074104008
Brand Curosurf®Infasurf®Survanta®Curosurf®Survanta®
Manufacturer Chiesi USA IncONYAbbVie IncChiesi USA IncAbbVie Inc
Invoice CUROSURF, VL 80MG/ML 3MLINFASURF, VL 35MG/ML 6ML D/SSURVANTA, SUSP INTRATRACHEAL 25MG/ML 4MLCUROSURF, VL 80MG/ML 1.5 MLSURVANTA , VL 25MG/ML 8ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 17256701630219
Container Type Single-Use VialSingle-Use VialVialSingle-Use VialVial
Country of Origin UnknownUnited StatesUnknownUnknownUnknown
Generic Drug Code 9089392809028710293902871
Generic Drug Name Poractant Alfa, Preservative FreeCalfactantBeractantPoractant Alfa, Preservative FreeBeractant
NDC Number 1012205100361938045606000741040041012205100100074104008
Strength 80 mg / mL35 mg / mL25 mg / mL80 mg / mL25 mg / mL
UNSPSC Code 5116170951161710511617025116170951161702
Volume 3 mL6 mL4 mL1.5 mL8 mL
Application Pulmonary SurfactantPulmonary SurfactantPulmonary SurfactantPulmonary SurfactantPulmonary Surfactant
Dosage Form SuspensionSuspensionSuspensionSuspensionSuspension
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Type IntratrachealIntratrachealIntratrachealIntratrachealIntratracheal
Features and Benefits
  • Ready-to-use suspension
  • CUROSURF® (poractant alfa) is intended for intratracheal use only
  • Intratracheal suspension
  • CUROSURF is a surfactant indicated for the rescue treatment, including the reduction of mortality and pneumothoraces, of Respiratory Distress Syndrome (RDS) in premature infants
  • CUROSURF® (poractant alfa) is intended for intratracheal use only
  • SURVANTA is indicated for prevention and treatment (“rescue%XE2%X80?) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
  • Store refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit)